Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 New standard of care for cervical cancer sets stage for next questions.

× No keyword cloud information.

13 in total

1. The PRICE study: The role of conventional and diffusion-weighted magnetic resonance imaging in assessment of locally advanced cervical cancer patients administered by chemoradiation followed by radical surgery.

Authors: A L Valentini; M Miccò; B Gui; M Giuliani; E Rodolfino; A M Telesca; T Pasciuto; A Testa; M A Gambacorta; G Zannoni; V Rufini; A Giordano; V Valentini; G Scambia; R Manfredi
Journal: Eur Radiol Date: 2018-01-09 Impact factor: 5.315

2. Implementing chemoradiation treatment for patients with cervical cancer in a comprehensive cancer center community oncology practice.

Authors: Charles Kunos; Gina Ferris; Steven Waggoner
Journal: Community Oncol Date: 2010-10

Review 3. DNA hypermethylation biomarkers to predict response to cisplatin treatment, radiotherapy or chemoradiation: the present state of art.

Authors: Frank Roossink; Steven de Jong; G Bea A Wisman; Ate G J van der Zee; Ed Schuuring
Journal: Cell Oncol (Dordr) Date: 2012-07-27 Impact factor: 6.730

4. Systemic therapy for cervical carcinoma - current status.

Authors: Krystyna Serkies; Jacek Jassem
Journal: Chin J Cancer Res Date: 2018-04 Impact factor: 5.087

5. A phase II randomized trial comparing radiotherapy with concurrent weekly cisplatin or weekly paclitaxel in patients with advanced cervical cancer.

Authors: Fady B Geara; Ali Shamseddine; Ali Khalil; Mirna Abboud; Maya Charafeddine; Muhieddine Seoud
Journal: Radiat Oncol Date: 2010-09-23 Impact factor: 3.481

6. Impact of age on morbidity and outcome of concurrent radiochemotherapy in high-risk FIGO stage I to IVA carcinoma of the uterine cervix following laparoscopic surgery.

Authors: Thea Laurentius; Annelore Altendorf-Hofmann; Oumar Camara; Ingo B Runnebaum; Thomas G Wendt
Journal: J Cancer Res Clin Oncol Date: 2010-05-15 Impact factor: 4.553

7. Chemotherapy Administration during Pelvic Radiation for Cervical Cancer Patients Aged >/=55 Years in the SEER-Medicare Population.

Authors: Charles Kunos; Heidi Gibbons; Fiona Simpkins; Steven Waggoner
Journal: J Oncol Date: 2008-08-27 Impact factor: 4.375

8. Secreted factors from bone marrow stromal cells upregulate IL-10 and reverse acute kidney injury.

Authors: Jack M Milwid; Takaharu Ichimura; Matthew Li; Yunxin Jiao; Jungwoo Lee; Joshua S Yarmush; Biju Parekkadan; Arno W Tilles; Joseph V Bonventre; Martin L Yarmush
Journal: Stem Cells Int Date: 2012-12-19 Impact factor: 5.443

9. Polarisation of Tumor-Associated Macrophages toward M2 Phenotype Correlates with Poor Response to Chemoradiation and Reduced Survival in Patients with Locally Advanced Cervical Cancer.

Authors: Marco Petrillo; Gian Franco Zannoni; Enrica Martinelli; Luigi Pedone Anchora; Gabriella Ferrandina; Giovanna Tropeano; Anna Fagotti; Giovanni Scambia
Journal: PLoS One Date: 2015-09-03 Impact factor: 3.240

10. Serum zinc as a prognostic indicator in locally advanced cancer cervix patients receiving chemo-irradiation: A pilot study.

Authors: Vivek Tiwari; Piyush Shukla; Gourav Gupta
Journal: South Asian J Cancer Date: 2014-01